Thursday, April 16, 2015 6:39:11 PM
HERBORIUM is working on several additions to its Product Portfolio. The near term products under development and consideration include:
The Liver Activator Series® Complimentary Liver Support Products that target liver damage resulting from Hepatitis C, Hepatitis B, and Cirrhosis and focus on regaining liver wellness compromised by alcohol, drugs and environmental factors. The leading product that supports both liver wellness and treatment is Liver Rejuvenator®
ProstAid an all natural product focused on Benign Prostate Hyperplasia (BPH) and ProstCare a similar product that targets Prostatitis
CardioVitae® a proprietary, fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. An enriched extract derived from a Ganoderma lucidium cell line that helps improve and accelerate recovery from cerebrovascular strokes is also under consideration.
The Company focuses on health needs with large market potential as defined by the number of patients and the demonstrated need for more satisfactory medical solutions.
Additional priority products identified by Herborium include:
Men’s Health (Benign Prostate Hyperplasia)
Hepatic Disease including Hepatitis and Cirrhosis and Improve hepatic function in patients with chronic liver disease
Antibiotic resistant pulmonary infections
Rheumatoid Arthritis
Cancer
Diabetes
GO HBRM $$$$$$
Penny stocks have earned their bad reputation, so beware.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM